Novo Nordisk (NOVOB DC) says Wegovy resulted in a BMI reduction of 10% or more in almost 80% of children aged 6-12
Newsquawk Staff ·
Novo Nordisk (NOVOB DC) says Wegovy resulted in a BMI reduction of 10% or more in almost 80% of children aged 6-12.
What it means
Paediatric readouts of this kind sit on the label-expansion pathway rather than the revenue line directly; the established sequence is data presentation, regulatory filing for an extended indication in the younger cohort, then the slower question of payer formulary placement, which in obesity has historically been the binding constraint rather than efficacy. The distinction worth drawing is between regulatory approval and reimbursement: prior episodes in the GLP-1 complex have shown approval arriving well before broad coverage, particularly in populations where long-term safety follow-up is still accruing, and paediatric use sharpens that scrutiny given the longer treatment horizon. For Novo specifically, the read-across is competitive: its obesity franchise trades against the rival incretin pipeline, and incremental indication breadth has tended to matter for the relative narrative more than for near-term estimates, with the equity historically reacting more to supply capacity and to comparative efficacy against the peer set than to single subgroup readouts. Follow-ons are the full dataset at a medical meeting, any regulatory filing timeline, and whether the competitor has comparable paediatric programmes in motion. As a single topline efficacy figure without safety detail or a filing commitment, the information content is confirmatory rather than thesis-changing.
Sources
- The Bank of Italy is reportedly conducting an inspection into Revolut regarding transparency and consumer protection
- Zealand Pharma (ZEAL DC) targets 10 new clinical programmes by 2030 focused on metabolic health, according to remarks at a Jefferies conference
- EU antitrust chief Ribera says she would like to see more cross-border bank mergers in the future
- Banco BPM (BAMI IM) CEO says a potential deal with Credit Agricole (ACA FP) is not a done deal
- Maersk (MAERSKB DC) announces AE1, AE2 and AE3 Gemini services will now sail through the Trans-Suez route instead of via the Cape of Good Hope
Related headlines
- EUROPEAN OPEN: SSNLF to manufacture STM FP chips for SPCX; NOVOB DC updates on CagriSema/Wegovy; AZN LN cuts around 600 US jobs, wins EU myasthenia gravis approval; BARC LN prepares 200 IB job cuts; STLAM IM faces Canada threat over Brampton deal7 hours ago
- Additional European Equity News - 16th November 20267 hours ago
- European Pre-Market Summary - 16th November 2026: European bourses set for a flat open8 hours ago
- Newsquawk Daily European Equity Opening News - 16th November 20268 hours ago
- Morgan Stanley lifts European Equities to Overweight from Neutral; upgrades Japanese Equities to Overweight from Neutral; raises its Global Equities rating to Overweight8 hours ago
- Novo Nordisk (NOVOB DC) says the European Commission has granted marketing authorisation for FREHEMGO (denecimig) as routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with haemophilia A2 days ago
- Germany plans to purchase 16 additional A400M military transport aircraft from Airbus (AIR FP)3 days ago
- India's Trade Secretary says the issues around scotch imports from the UK will resolve soon3 days ago
- [MARKET ANALYSIS] European bourses most lower, with Luxury hit after Richemont earnings3 days ago
- EUROPEAN OPEN: CFR SW H1 op profit up sharply; BC8 GY raises EBT outlook; AMS SW Q3 revenue miss; BOSS GY appoints new CEO; STLAM IM faces potential Canada lawsuit; CARLB DC plans USD 600mln India IPO3 days ago
- European Movers: Richemont (CFR SW) -8%, Generali (G IM) -1.5%, Acciona (ANA SM) +3%3 days ago
- European Pre-Market Equity Summary, 13th November 2026: Strong earnings from Enel, mixed from Generali3 days ago
- Additional European Equity News - 13th November 20263 days ago
- Newsquawk Daily European Equity Opening News - 13th November 20263 days ago
- Enel (ENEL IM) 9M 2026 (EUR): Revenue 65.02bln (prev. 60bln Y/Y); Adj. EBITDA 18bln (exp. 17.7bln); Adj. net income 6.02bln (prev. 5.7bln Y/Y)3 days ago